FREE MEMBERSHIP Includes » ABL Advisor eNews + iData Blasts | JOIN NOW ABLAdvisor Gray ABLAdvisor Blue
Skip Navigation LinksHome / News / Read News


Barclays Appoints New Head of US West Coast Biotech Banking

December 11, 2018, 07:05 AM
Related: Barclays, Biotech

Barclays announced the appointment of David Parrot as Managing Director and Head of Barclays’ US West Coast Biotech Banking franchise. Parrot will be based in Menlo Park, California, and will report to Rick Landgarten, Global Head of Healthcare & Real Estate Groups at Barclays.

Parrot joins Barclays with close to 30 years of experience in banking, most recently as Head of Life Science Investment Banking at SunTrust Robinson Humphrey. Prior to joining SunTrust in 2015,  Parrot was Co-Head of Life Science Investment Banking at BMO Capital Markets. Mr. Parrot joined BMO Capital Markets in 2010 after spending one year at Montgomery & Co., prior to which he was a founding member of the Life Sciences Investment Banking Group at Piper Jaffray & Co., joining in 1998.

“As Biotech continues to see rapid and marked evolution, we are excited about the great value David’s experience and abilities will bring to our clients,” said Rick Landgarten, Global Head of Healthcare & Real Estate Groups. “David’s hire is further evidence of our significant investment of resources in our strong Biotech franchise, and his deep and longstanding industry relationships and extensive transactional expertise make him a superb addition to our team.”

“Barclays is committed to investing in top talent to enable us to continue to drive mind and market share with our clients, and this is perfectly demonstrated in David’s hire,” added John Miller, Global Head of Banking Coverage. “The Biotech space represents a critical opportunity-set for our investment banking business, and David’s addition to the team will ensure that we continue to build on the strong momentum in our broader Healthcare franchise.”

Parrot is expected to start in early March 2019.

Comments From Our Members

You must be an ABL Advisor member to post comments. Login or Join Now.